pharma is the sole category represented across all 1 tracked stories. ICPO Foundation is most often covered alongside Theranostics, which appears in 1 of these 1 story. We currently track 1 Biotech story that mention ICPO Foundation, all published on February 25, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about ICPO Foundation
pharma is the sole category represented across all 1 tracked stories. ICPO Foundation is most often covered alongside Theranostics, which appears in 1 of these 1 story. We currently track 1 Biotech story that mention ICPO Foundation, all published on February 25, 2026. Each carries 2 original sources on average.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 16 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering ICPO Foundation. Shared-story counts are live from our verified record — not editorial picks.
The ICPO Foundation and the World Federation of Nuclear Medicine and Biology (WFNMB) have entered a strategic partnership to accelerate the global adoption of Theranostics. This collaboration focuses on standardizing precision oncology practices and expanding nuclear medicine infrastructure to improve patient outcomes worldwide.
ICPO Foundation is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.